Publications for Sandra O'Toole
Publications for Sandra O'Toole
2014.08.08">[More Information]</a>
2016
Loh, S., Cooper, C., Selinger, C., Barnes, E.,
Chan, C., Carmalt, H., West, R., Gluch, L.,
Beith, J., Caldon, C., O'Toole, S. (2015). Cell
cycle marker expression in benign and malignant
intraductal papillary lesions of the breast.
Journal of Clinical Pathology, 68(3), 187-191.
<a
href="http://dx.doi.org/10.1136/jclinpath-2014-2
02331">[More Information]</a>
Tran, T., Selinger, C., Kohonen-Corish, M.,
McCaughan, B., Kennedy, C., O'Toole, S.,
Cooper, W. (2016). Alterations of MET Gene
Copy Number and Protein Expression in Primary
Non-Small-Cell Lung Cancer and Corresponding
Nodal Metastases. Clinical Lung Cancer, 17(1),
30-38. <a
href="http://dx.doi.org/10.1016/j.cllc.2015.08.00
2">[More Information]</a>
Luk, P., Wykes, J., Selinger, C., Ekmejian, R.,
Tay, J., Gao, K., Eviston, T., Lum, T., O'Toole,
S., Clark, J., Gupta, R. (2016). Diagnostic and
prognostic utility of Mastermind-like 2
(MAML2) gene rearrangement detection by
fluorescent in situ hybridization (FISH) in
mucoepidermoid carcinoma of the salivary
glands. Oral Surgery, Oral Medicine, Oral
Pathology, Oral Radiology, 121(5), 530-541. <a
href="http://dx.doi.org/10.1016/j.oooo.2016.01.0
03">[More Information]</a>
Luk, P., Weston, J., Yu, B., Selinger, C.,
Ekmejian, R., Eviston, T., Lum, T., Gao, K.,
Boyer, M., O'Toole, S., Clark, J., Gupta, R.
(2016). Salivary duct carcinoma:
Clinicopathologic features, morphologic
spectrum, and somatic mutations. Head and
Neck, 38(Suppl 1), e1838-e1847. <a
href="http://dx.doi.org/10.1002/hed.24332">[Mo
re Information]</a>
Lyle, M., Haydu, L., Menzies, A., Thompson, J.,
Saw, R., Spillane, A., Kefford, R., Mann, G.,
Cooper, W., Yu, B., Scolyer, R., O'Toole, S.,
Long, G. (2016). The molecular profile of
metastatic melanoma in Australia. Pathology,
48(2), 188-193. <a
href="http://dx.doi.org/10.1016/j.pathol.2015.12.
008">[More Information]</a>
2015
Chou, A., Fraser, S., Toon, C., Clarkson, A.,
Sioson, L., Farzin, M., Cussigh, C., Aniss, A.,
O'Neill, C., Watson, N., Clifton-Bligh, R.,
Learoyd, D., Robinson, B., Delbridge, L., Sidhu,
S., O'Toole, S., Sywak, M., Gill, A., et al (2015).
A Detailed Clinicopathologic Study of
ALK-translocated Papillary Thyroid Carcinoma.
American Journal of Surgical Pathology, 39(5),
652-659. <a
href="http://dx.doi.org/10.1097/PAS.000000000
0000368">[More Information]</a>
Luk, P., Yu, B., Ng, C., Mercorella, B., Selinger,
C., Lum, T., Kao, S., O'Toole, S., Cooper, W.
(2015). BRAF mutations in non-small cell lung
cancer. Translational Lung Cancer Research,
4(2), 142-148. <a
href="http://dx.doi.org/10.3978/j.issn.2218-6751.
Gallego-Ortega, D., Ledger, A., Roden, D., Law,
A., Magenau, A., Kikhtyak, Z., Cho, C.,
Allerdice, S., Lee, H., Valdes-Mora, F., Naylor,
M., O'Toole, S., et al (2015). ELF5 Drives Lung
Metastasis in Luminal Breast Cancer through
Recruitment of Gr1+ CD11b+ Myeloid-Derived
Suppressor Cells. PLoS Biology, 13(12), 1-27. <a
href="http://dx.doi.org/10.1371/journal.pbio.100
2330">[More Information]</a>
Li, B., Lee, A., O'Toole, S., Cooper, W., Yu, B.,
Chaft, J., Arcila, M., Kris, M., Pavlakis, N.
(2015). HER2 insertion YVMA mutant lung
cancer: Long natural history and response to
afatinib. Lung Cancer, 90(3), 617-619. <a
href="http://dx.doi.org/10.1016/j.lungcan.2015.1
0.025">[More Information]</a>
Junankar, S., Baker, L., Roden, D., Nair, R.,
Elsworh, B., Gallego-Ortega, D., Lacaze, P.,
Cazet, A., Nikolic, I., Teo, W., Naylor, M.,
O'Toole, S., et al (2015). ID4 controls mammary
stem cells and marks breast cancers with a stem
cell-like phenotype. Nature Communications, 6,
1-12. <a
href="http://dx.doi.org/10.1038/ncomms7548">[
More Information]</a>
Luk, P., Selinger, C., Eviston, T., Lum, T., Yu,
B., O'Toole, S., Clark, J., Gupta, R. (2015).
Mammary analogue secretory carcinoma: an
evaluation of its clinicopathological and genetic
characteristics. Pathology, 47(7), 659-666. <a
href="http://dx.doi.org/10.1097/PAT.000000000
0000322">[More Information]</a>
Phua, Y., Nguyen, A., Roden, D., Elsworth, B.,
Deng, N., Nikolic, I., Yang, J., McFarland, A.,
Russell, R., Kaplan, W., O'Toole, S., James, D.,
et al (2015). MicroRNA profiling of the pubertal
mouse mammary gland identifies miR-184 as a
candidate breast tumour suppressor gene. Breast
Cancer Research, 17(1), 1-18. <a
href="http://dx.doi.org/10.1186/s13058-015-059
3-0">[More Information]</a>
Gee, H., Buffa, F., Harris, A., Toohey, J.,
Carroll, S., Cooper, C., Beith, J., McNeil, C.,
Carmalt, H., Mak, C., Kennedy, C., O'Toole, S.,
et al (2015). MicroRNA-Related DNA repair/
cell-cycle genes independently associated with
relapse after radiation therapy for early breast
cancer. International Journal of Radiation
Publications for Sandra O'Toole
Oncology: Biology Physics, 93(5), 1104-1114.
<a
href="http://dx.doi.org/10.1016/j.ijrobp.2015.08.
046">[More Information]</a>
Cooper, W., Tran, T., Vilain, R., Madore, J.,
Selinger, C., Kohonen-Corish, M., Yip, P., Yu,
B., O'Toole, S., McCaughan, B., Horvath, L.,
Kao, S., Boyer, M., Scolyer, R., et al (2015).
PD-L1 expression is a favorable prognostic
factor in early stage non-small cell carcinoma.
Lung Cancer, 89(2), 181-188. <a
href="http://dx.doi.org/10.1016/j.lungcan.2015.0
5.007">[More Information]</a>
Warrier, S., Hwang, S., Gibbings, K., Carmalt,
H., O'Toole, S. (2015). Phyllodes tumour with
heterologous sarcomatous differentiation: Case
series with literature review. International
Journal of Surgery Case Reports, 11, 91-94. <a
href="http://dx.doi.org/10.1016/j.ijscr.2015.02.0
09">[More Information]</a>
Yu, B., O'Toole, S., Trent, R. (2015). Somatic
DNA mutation analysis in targeted therapy of
solid tumours. Translational Pediatrics, 4(2),
125-138. <a
href="http://dx.doi.org/10.3978/j.issn.2224-4336.
2015.04.04">[More Information]</a>
Wang, S., Yu, B., Ng, C., Mercorella, B.,
Selinger, C., O'Toole, S., Cooper, W. (2015).
The suitability of small biopsy and cytology
specimens for EGFR and other mutation testing
in non-small cell lung cancer. Translational
Lung Cancer Research, 4(2), 119-125. <a
href="http://dx.doi.org/10.3978/j.issn.2218-6751.
2015.01.05">[More Information]</a>
2014
Gibbings, K., Warrier, S., Hwang, S., Rice, M.,
O'Toole, S., Carmalt, H. (2014). A giant
phyllodes tumour with sepsis. ANZ Journal of
Surgery, 84(11), 886-887. <a
href="http://dx.doi.org/10.1111/ans.12340">[Mo
re Information]</a>
Tran, T., Selinger, C., Yu, B., Ng, C.,
Kohonen-Corish, M., McCaughan, B., Kennedy,
C., O'Toole, S., Cooper, W. (2014). Alterations
of insulin-like growth factor-1 receptor gene
copy number and protein expression are common
in non-small cell lung cancer. Journal of Clinical
Pathology, 67(11), 985-991. <a
href="http://dx.doi.org/10.1136/jclinpath-2014-2
02347">[More Information]</a>
Nair, R., Roden, D., Teo, W., McFarland, A.,
Junankar, S., Ye, S., Nguyen, A., Yang, J.,
Nicolic, I., Hui, M., Armstrong, N., Naylor, M.,
O'Toole, S., et al (2014). c-Myc and Her2
cooperate to drive a stem-like phenotype with
poor prognosis in breast cancer. Oncogene,
33(30), 3992-4002. <a
href="http://dx.doi.org/10.1038/onc.2013.368">[
More Information]</a>
Kakavand, H., Crainic, O., Lum, T., O'Toole, S.,
Kefford, R., Thompson, J., Wilmott, J., Long, G.,
Scolyer, R. (2014). Concordant BRAFV600E
mutation status in primary melanomas and
associated naevi: implications for mutation
testing of primary melanomas. Pathology, 46(3),
193-198. <a
href="http://dx.doi.org/10.1097/PAT.000000000
0000077">[More Information]</a>
Carlino, M., Haydu, L., Kakavand, H., Menzies,
A., Hamilton, A., Yu, B., Ng, C., Cooper, W.,
Thompson, J., Kefford, R., O'Toole, S., Scolyer,
R., Long, G. (2014). Correlation of BRAF and
NRAS mutation status with outcome, site of
distant metastasis and response to chemotherapy
in metastatic melanoma. British Journal of
Cancer, 111(2), 292-299. <a
href="http://dx.doi.org/10.1038/bjc.2014.287">[
More Information]</a>
Houang, M., Sioson, L., Clarkson, A., Watson,
N., Mahtab, F., Toon, C., Raut, A., O'Toole, S.,
Cooper, W., Pavlakis, N., Gill, A., et al (2014).
EGFR mutation specific immunohistochemistry
is a useful adjunct which helps to identify false
negative mutation testing in lung cancer.
Pathology, 46(6), 501-508. <a
href="http://dx.doi.org/10.1097/PAT.000000000
0000141">[More Information]</a>
Menzies, A., Lum, T., Wilmott, J., Hyman, J.,
Kefford, R., Thompson, J., O'Toole, S., Long,
G., Scolyer, R. (2014). Intrapatient Homogeneity
of BRAFV600E Expression in Melanoma. The
American Journal of Surgical Pathology, 38(3),
377-382. <a
href="http://dx.doi.org/10.1097/PAS.000000000
0000136">[More Information]</a>
O'Toole, S., Yu, B., Cooper, W. (2014).
Molecular Diagnosis in Cytology and Its Place in
the New Classification: A Practical Guide. The
Journal of OncoPathology, 2(1), 63-73. <a
href="http://dx.doi.org/10.13032/tjop.2052-5931.
100080.">[More Information]</a>
Cooper, W., Fox, S., O'Toole, S., Morey, A.,
Frances, G., Pavlakis, N., O'Brien, K., Dettrick,
A., Leong, T., Rathi, V., et al (2014). National
Working Group Meeting on ALK diagnostics in
lung cancer. Asia-Pacific Journal of Clinical
Oncology, 10(S 2), 11-17. <a
href="http://dx.doi.org/10.1111/ajco.12190">[M
ore Information]</a>
Houang, M., Toon, C., Clarkson, A., Sioson, L.,
Watson, N., Farzin, M., Selinger, C., Chou, A.,
Morey, A., Cooper, W., O'Toole, S., Gill, A.
(2014). Reflex ALK immunohistochemistry is
feasible and highly specific for ALK gene
rearrangements in lung cancer. Pathology, 46(5),
Publications for Sandra O'Toole
383-388. <a
href="http://dx.doi.org/10.1097/PAT.000000000
0000114">[More Information]</a>
Nguyen, N., Hampartzoumian, T., Cameron, B.,
Palmer, C., O'Toole, S., Post, J., Zekry, A.,
Lloyd, A. (2014). Regulation of T cell
recruitment and inflammation in the human
immunodeficiency virus/hepatitis C virus
coinfected liver. Journal of Gastroenterology
and Hepatology, 29(7), 1535-1543. <a
href="http://dx.doi.org/10.1111/jgh.12543">[Mo
re Information]</a>
2013
Schade, B., Lesurf, R., Sanguin-Gendreau, V.,
Bui, T., Deblois, G., O'Toole, S., Millar, E.,
Zardawi, S., Lopez-Knowles, E., Sutherland, R.,
et al (2013). B-Catenin Signaling is a Critical
Event in ErbB2-Mediated Mammary Tumor
Progression. Cancer Research, 73(14),
4474-4487. <a
href="http://dx.doi.org/10.1158/0008-5472.CAN
-12-3925">[More Information]</a>
Klein, O., Clements, A., Menzies, A., O'Toole,
S., Kefford, R., Long, G. (2013). BRAF inhibitor
activity in V600R metastatic melanoma.
European Journal of Cancer, 49(5), 1073-1079.
<a
href="http://dx.doi.org/10.1016/j.ejca.2012.11.00
4">[More Information]</a>
Klein, O., Clements, A., Menzies, A., O'Toole,
S., Kefford, R., Long, G. (2013). BRAF inhibitor
activity in V600R metastatic melanoma –
Response. European Journal of Cancer, 49(7),
1797-1798. <a
href="http://dx.doi.org/10.1016/j.ejca.2013.02.01
0">[More Information]</a>
O'Toole, S., Rakha, E., Ellis, I., Tan, P. (2013).
Breast pathology today: morphology and
molecules. Journal of Clinical Pathology, 66(6),
457. <a
href="http://dx.doi.org/10.1136/jclinpath-2013-2
01660">[More Information]</a>
Cooper, C., O'Toole, S., Kench, J. (2013).
Classification, morphology and molecular
pathology of premalignant lesions of the
pancreas. Pathology, 45(3), 286-304. <a
href="http://dx.doi.org/10.1097/PAT.0b013e328
35f2205">[More Information]</a>
Cooper, W., Yu, B., Yip, P., Ng, C., Lum, T.,
Farzin, M., Trent, R., Mercorella, B., Clarkson,
A., Kohonen-Corish, M., Horvath, L., Kench, J.,
McCaughan, B., Gill, A., O'Toole, S. (2013).
EGFR mutant-specific immunohistochemistry
has high specificity and sensitivity for detecting
targeted activating EGFR mutations in lung
adenocarcinoma. Journal of Clinical Pathology,
66(9), 744-748. <a
href="http://dx.doi.org/10.1136/jclinpath-2013-2
01607">[More Information]</a>
Tran, T., Selinger, C., Kohonen-Corish, M.,
McCaughan, B., Kennedy, C., O'Toole, S.,
Cooper, W. (2013). Fibroblast growth factor
receptor 1 (FGFR1) copy number is an
independent prognostic factor in non-small cell
lung cancer. Lung Cancer, 81(3), 462-467. <a
href="http://dx.doi.org/10.1016/j.lungcan.2013.0
5.015">[More Information]</a>
Browne, B., Hochgrafe, F., Wu, J., Millar, E.,
Barraclough, J., Stone, A., McCloy, R., Lee, C.,
Roberts, C., Ali, N., O'Toole, S., et al (2013).
Global characterization of signalling networks
associated with tamoxifen resistance in breast
cancer. The FEBS Journal, 280(21), 5237-5257.
<a
href="http://dx.doi.org/10.1111/febs.12441">[M
ore Information]</a>
Cooper, C., Karim, R., Selinger, C., Carmalt, H.,
Lee, C., O'Toole, S. (2013). Molecular
alterations in metaplastic breast carcinoma.
Journal of Clinical Pathology, 66(6), 522-528.
<a
href="http://dx.doi.org/10.1136/jclinpath-2012-2
01086">[More Information]</a>
Cooper, W., Lam, D., O'Toole, S., Minna, J.
(2013). Molecular biology of lung cancer.
Journal of Thoracic Disease, 5(S5), S479-S490.
<a
href="http://dx.doi.org/10.3978/j.issn.2072-1439.
2013.08.03">[More Information]</a>
Cooper, W., O'Toole, S. (2013). Molecular
Pathology in lung Cancer. Cancer Forum, 37(2),
1-7.
Yip, P., Yu, B., Cooper, W., Selinger, C., Ng, C.,
Kennedy, C., Kohonen-Corish, M., McCaughan,
B., Trent, R., Boyer, M., Kench, J., Horvath, L.,
O'Toole, S. (2013). Patterns of DNA mutations
and ALK Rearrangement in Resected Node
Negative Lung Adenocarcinoma. Journal of
Thoracic Oncology, 8(4), 408-414. <a
href="http://dx.doi.org/10.1097/JTO.0b013e3182
83558e">[More Information]</a>
Saunderson, R., Garsia, R., Headley, A.,
McCaughan, G., O'Toole, S., Strasser, S. (2013).
Pentoxifylline-induced drug rash with
eosinophilia and systemic symptoms (DRESS) in
a patient with caffeine intolerance. Journal of
Dermatological Case Reports, 7(3), 77-81. <a
href="http://www.ncbi.nlm.nih.gov/entrez/query.
fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract
&list_uids=24133560">[More Information]</a>
Karim, R., O'Toole, S., Scolyer, R., Cooper, C.,
Chan, B., Selinger, C., Yu, B., Carmalt, H., Mak,
C., Tse, G., Lee, C., et al (2013). Recent insights
into the molecular pathogenesis of mammary
Publications for Sandra O'Toole
phyllodes tumours. Journal of Clinical
Pathology, 66(6), 496-505. <a
href="http://www.ncbi.nlm.nih.gov/entrez/query.
fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract
&list_uids=23404800">[More Information]</a>
Shields, B., Wiede, F., Gurzov, E., Wee, K.,
Hauser, C., Zhu, H., Molloy, T., O'Toole, S.,
Daly, R., Sutherland, R., et al (2013). TCPTP
Regulates SFK and STAT3 Signaling and Is Lost
in Triple-Negative Breast Cancers. Molecular
and Cellular Biology, 33(3), 557-570. <a
href="http://dx.doi.org/10.1128/MCB.01016-12"
>[More Information]</a>
Selinger, C., Rogers, T., Russell, P., O'Toole, S.,
Yip, P., Wright, G., Wainer, Z., Horvath, L.,
Boyer, M., McCaughan, B., et al (2013). Testing
for ALK rearrangement in lung adenocarcinoma:
A multicenter comparison of
immunohistochemistry and fluorescent in situ
hybridization. Modern Pathology, 26(12),
1545-1553. <a
href="http://dx.doi.org/10.1038/modpathol.2013.
87">[More Information]</a>
Hui, M., Cazet, A., Nair, R., Watkins, D.,
O'Toole, S., Swarbrick, A. (2013). The
Hedgehog signalling pathway in breast
development, carcinogenesis and cancer therapy.
Breast Cancer Research, 15(2), 1-14. <a
href="http://dx.doi.org/10.1186/bcr3401">[More
Information]</a>
O'Toole, S., Beith, J., Millar, E., West, R.,
McLean, A., Cazet, A., Swarbrick, A., Oakes, S.
(2013). Therapeutic targets in triple negative
breast cancer. Journal of Clinical Pathology,
66(6), 530-542. <a
href="http://dx.doi.org/10.1136/jclinpath-2012-2
01361">[More Information]</a>
2012
Coates, A., Millar, E., O'Toole, S., Molloy, T.,
Viale, G., Goldhirsch, A., Regan, M., Gelber, R.,
Sun, Z., Castiglione-Gertsch, M., et al (2012).
Prognostic interaction between expression of p53
and estrogen receptor in patients with
node-negative breast cancer: results from IBCSG
Trials VIII and IX. Breast Cancer Research,
14(6), 1-12. <a
href="http://dx.doi.org/10.1186/bcr3348">[More
Information]</a>
2011
Xu, H., Yan, M., Patra, J., Natrajan, R., Yan, Y.,
Swagemakers, S., Tomaszewski, J., Verschoor,
S., Millar, E., van der Spek, P., O'Toole, S.,
McNeil, C., et al (2011). Enhanced RAD21
cohesin expression confers poor prognosis and
resistance to chemotherapy in high grade
luminal, basal and HER2 breast cancers. Breast
Cancer Research, 13(1), R9-1-R9-36. <a
href="http://dx.doi.org/10.1186/bcr2814">[More
Information]</a>
O'Toole, S., Machalek, D., Shearer, R., Millar,
E., Nair, R., Schofield, P., McLeod, D., Cooper,
C., McNeil, C., McFarland, A., et al (2011).
Hedgehog Overexpression Is Associated with
Stromal Interactions and Predicts for Poor
Outcome in Breast Cancer. Cancer Research,
71(11), 4002-4014. <a
href="http://dx.doi.org/10.1158/0008-5472.CAN
-10-3738">[More Information]</a>
Roberts, C., Millar, E., O'Toole, S., McNeil, C.,
Lehrbach, G., Pinese, M., Tobelmann, P.,
McCloy, R., Musgrove, E., Sutherland, R., et al
(2011). Identification of PUMA as an estrogen
target gene that mediates the apoptotic response
to tamoxifen in human breast cancer cells and
predicts patient outcome and tamoxifen
responsiveness in breast cancer. Oncogene,
30(28), 3186-3197. <a
href="http://dx.doi.org/10.1038/onc.2011.36">[
More Information]</a>
O'Toole, S., Selinger, C., Millar, E., Lum, T.,
Beith, J. (2011). Molecular assays in breast
cancer pathology. Pathology, 43(2), 116-127. <a
href="http://dx.doi.org/10.1097/PAT.0b013e328
3430926">[More Information]</a>
Millar, E., Graham, P., McNeil, C., Browne, L.,
O'Toole, S., Boulghourjian, A., Kearsley, J.,
Papadatos, G., Delaney, G., Fox, C., et al (2011).
Prediction of outcome of early ER + breast
cancer is improved using a biomarker panel,
which includes Ki-67 and p53. British Journal of
Cancer, 105(2), 272-280. <a
href="http://dx.doi.org/10.1038/bjc.2011.228">[
More Information]</a>
Colvin, E., Susanto, J., Kench, J., Ong, V.,
Mawson, A., Pinese, M., Chang, D., Rooman, I.,
O'Toole, S., Segara, D., et al (2011). Retinoid
signaling in pancreatic cancer, injury and
regeneration. PloS One, 6(12), e29075 1-e29075 - 10. <a
href="http://dx.doi.org/10.1371/journal.pone.002
9075">[More Information]</a>
Chan, P., Möller, A., Liu, M., Sceneay, J., Wong,
C., Waddell, N., Huang, K., Dobrovic, A.,
Millar, E., O'Toole, S., et al (2011). The
expression of the ubiquitin ligase SIAH2 (seven
in absentia homolog 2) is mediated through gene
copy number in breast cancer and is associated
with a basal-like phenotype and p53 expression.
Breast Cancer Research, 13(1), 1-10. <a
href="http://dx.doi.org/10.1186/bcr2828">[More
Information]</a>
Cooper, W., O'Toole, S., Boyer, M., Horvath, L.,
Mahar, A. (2011). What's new in non-small cell
lung cancer for pathologists: the importance of
accurate subtyping, EGFR mutations and ALK
Publications for Sandra O'Toole
rearrangements. Pathology, 43(2), 103-115. <a
href="http://dx.doi.org/10.1097/PAT.0b013e328
342629d">[More Information]</a>
2010
Lopez-Knowles, E., Zardawi, S., McNeil, C.,
Millar, E., Crea, P., Musgrove, E., Sutherland,
R., O'Toole, S. (2010). Cytoplasmic Localization
of beta-Catenin is a Marker of Poor Outcome in
Breast Cancer Patients. Cancer Epidemiology,
Biomarkers and Prevention, 19(1), 301-309. <a
href="http://dx.doi.org/10.1158/1055-9965.EPI-0
9-0741">[More Information]</a>
Zardawi, S., Zardawi, I., McNeil, C., Millar, E.,
McLeod, D., Morey, A., Crea, P., Murphy, N.,
Pinese, M., Lopez-Knowles, E., Hamilton, A.,
Spillane, A., Lee, C., et al (2010). High Notch1
protein expression is an early event in breast
cancer development and is associated with the
HER-2 molecular subtype. Histopathology,
56(3), 286-296. <a
href="http://dx.doi.org/10.1111/j.1365-2559.200
9.03475.x">[More Information]</a>
Murphy, N., Biankin, A., Millar, E., McNeil, C.,
O'Toole, S., Segara, D., Crea, P., Olayioye, M.,
Lee, C., Fox, S., et al (2010). Loss of STARD10
expression identifies a group of poor prognosis
breast cancers independent of HER2/Neu and
triple negative status. International Journal of
Cancer, 126(6), 1445-1453. <a
href="http://dx.doi.org/10.1002/ijc.24826">[Mor
e Information]</a>
Fleuren, E., O'Toole, S., Millar, E., McNeil, C.,
Lopez-Knowles, E., Boulghourjian, A.,
Croucher, D., Schramek, D., Brummer, T.,
Penninger, J., et al (2010). Overexpression of the
oncogenic signal transducer Gab2 occurs early in
breast cancer development. International Journal
of Cancer, 127(6), 1486-92. <a
href="http://dx.doi.org/10.1002/ijc.25172">[Mor
e Information]</a>
Lopez-Knowles, E., O'Toole, S., McNeil, C.,
Millar, E., Qiu, M., Crea, P., Daly, R.,
Musgrove, E., Sutherland, R. (2010). PI3K
pathway activation in breast cancer is associated
with the basal-like phenotype and cancer-specific
mortality. International Journal of Cancer,
126(5), 1121-1131. <a
href="http://dx.doi.org/10.1002/ijc.24831">[Mor
e Information]</a>
Nair, R., Junankar, S., O'Toole, S., Shah, J.,
Borowsky, A., Bishop, J., Swarbrick, A. (2010).
Redefining the expression and function of the
inhibitor of differentiation 1 in mammary gland
development. PloS One, 5(8), 1-7. <a
href="http://dx.doi.org/10.1371/journal.pone.001
1947">[More Information]</a>
Palmer, C., Corpuz, T., Marianne, G., O'Toole,
S., Yan, K., Bu, Y., Jorgenson, J., Talbot, M.,
Loi, K., Lloyd, A., et al (2010). The effect of
obesity on intrahepatic cytokine and chemokine
expression in chronic hepatitis c infection. Gut
(English Edition): an international journal of
gastroenterology and hepatology, 59(3),
397-404. <a
href="http://dx.doi.org/10.1136/gut.2008.165316
">[More Information]</a>
Hochgrafe, F., Zhang, L., O'Toole, S., Browne,
B., Pinese, M., Cubas, A., Lehrbach, G.,
Lehrbach, D., Rickwood, D., Boulghourjian, A.
(2010). Tyrosine Phosphorylation Profiling
Reveals the Signaling Network Characteristics of
Basal Breast Cancer Cells. Cancer Research,
70(22), 9391-9401. <a
href="http://dx.doi.org/10.1158/0008-5472.CAN
-10-0911">[More Information]</a>
2009
Millar, E., Anderson, L., McNeil, C., O'Toole,
S., Pinese, M., Crea, P., Morey, A., Biankin, A.,
Henshall, S., Musgrove, E., et al (2009). BAG-1
predicts patient outcome and tamoxifen
responsiveness in ER-positive invasive ductal
carcinoma of the breast. British Journal of
Cancer, 100(1), 123-133. <a
href="http://dx.doi.org/10.1038/sj.bjc.6604809">
[More Information]</a>
Millar, E., Dean, J., McNeil, C., O'Toole, S.,
Henshall, S., Lin, J., Quong, A., Comstock, C.,
Witkiewicz, A., Musgrove, E., et al (2009).
Cyclin D1b protein expression in breast cancer is
independent of cyclin D1a and associated with
poor disease outcome. Oncogene, 28(15),
1812-1820. <a
href="http://dx.doi.org/10.1038/onc.2009.13">[
More Information]</a>
Zhang, J., O'Toole, S., Sutherland, R., Musgrove,
E. (2009). Dysregulation of Hedgehog, Wnt and
Notch signalling pathways in breast cancer.
Histology and histopathology, 24(3), 385-398. <a
href="http://www.ncbi.nlm.nih.gov/entrez/query.
fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract
&list_uids=19130408">[More Information]</a>
Kitzing, B., O'Toole, S., Waugh, A., Clayton, J.,
McGill, N., Allman, K. (2009). Hepatobiliary
scintigraphy in vasculitis of the gallbladder as a
manifestation of polyarteritis nodosa: a case
report. Cases Journal, 2, 9300. <a
href="http://dx.doi.org/10.1186/1757-1626-2-93
00">[More Information]</a>
Millar, E., Graham, P., O'Toole, S., McNeil, C.,
Browne, L., Morey, A., Eggleton, S., Beretov, J.,
Theocharous, C., Capp, A. (2009). Prediction of
local recurrence, distant metastases, and death
after breast-conserving therapy in early-stage
invasive breast cancer using a five-biomarker
panel. Journal of Clinical Oncology, 27(28),
Publications for Sandra O'Toole
4701-4708. <a
href="http://dx.doi.org/10.1200/JCO.2008.21.70
75">[More Information]</a>
O'Toole, S., Swarbrick, A., Sutherland, R.
(2009). The Hedgehog signalling pathway as a
therapeutic target in early breast cancer
development. Expert Opinion on Therapeutic
Targets, 13(9), 1095-1103. <a
href="http://dx.doi.org/10.1517/1472822090313
0612">[More Information]</a>
Tan, E., Yan, M., Campo, L., Han, C., Takano,
E., Turley, H., Candiloro, I., Pezzela, F., Gatter,
K., Millar, E., O'Toole, S., et al (2009). The key
hypoxia regulated gene CAIX is upregulated in
basal-like breast tumours and is associated with
resistance to chemotherapy. British Journal of
Cancer, 100(2), 405-411. <a
href="http://dx.doi.org/10.1038/sj.bjc.6604844">
[More Information]</a>